Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTX-TIC in Open-angle Glaucoma or Ocular Hypertension
NCT05335122Phase 2Completed
- Sponsor
- Ocular Therapeutix
- Start
- Mar 2022
- Primary completion
- Jan 2024
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OTX-TP in open-angle glaucoma (OAG), ocular hypertension, sponsored by Ocular Therapeutix. Started Mar 2022; status: completed.
02
Drugs
OTX-TP
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT05335122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05335122.